-
1
-
-
31544457877
-
P53 ubiquitination: Mdm2 and beyond
-
DOI 10.1016/j.molcel.2006.01.020, PII S1097276506000402
-
CL Brooks W Gu 2006 p53 ubiquitination: Mdm2 and beyond Mol Cell 21 307 315 10.1016/j.molcel.2006.01.020 1:CAS:528:DC%2BD28Xhslehurk%3D 16455486 (Pubitemid 43163526)
-
(2006)
Molecular Cell
, vol.21
, Issue.3
, pp. 307-315
-
-
Brooks, C.L.1
Gu, W.2
-
2
-
-
62449215026
-
Mdm2 affects genome stability independent of p53
-
10.1158/0008-5472.CAN-08-3732 1:CAS:528:DC%2BD1MXisFSrsbg%3D 19244108
-
A Bouska CM Eischen 2009 Mdm2 affects genome stability independent of p53 Cancer Res 69 1697 1701 10.1158/0008-5472.CAN-08-3732 1:CAS:528: DC%2BD1MXisFSrsbg%3D 19244108
-
(2009)
Cancer Res
, vol.69
, pp. 1697-1701
-
-
Bouska, A.1
Eischen, C.M.2
-
3
-
-
33750848203
-
Regulation of the p14ARF-Mdm2-p53 pathway: An overview in breast cancer
-
DOI 10.1016/j.yexmp.2006.07.001, PII S0014480006000803
-
A Agrawal J Yang RF Murphy DK Agrawal 2006 Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer Exp Mol Pathol 81 115 122 10.1016/j.yexmp.2006.07.001 1:CAS:528:DC%2BD28XpvFektbo%3D 16919268 (Pubitemid 44717514)
-
(2006)
Experimental and Molecular Pathology
, vol.81
, Issue.2
, pp. 115-122
-
-
Agrawal, A.1
Yang, J.2
Murphy, R.F.3
Agrawal, D.K.4
-
4
-
-
8844278362
-
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
-
DOI 10.1016/j.cell.2004.11.022, PII S0092867404010517
-
GL Bond W Hu EE Bond H Robins SG Lutzker NC Arva J Bargonetti F Bartel H Taubert P Wuerl K Onel L Yip SJ Hwang LC Strong G Lozano AJ Levine 2004 A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans Cell 119 591 602 10.1016/j.cell.2004.11.022 1:CAS:528:DC%2BD2cXhtVGls7bF 15550242 (Pubitemid 39535748)
-
(2004)
Cell
, vol.119
, Issue.5
, pp. 591-602
-
-
Bond, G.L.1
Hu, W.2
Bond, E.E.3
Robins, H.4
Lutzker, S.G.5
Arva, N.C.6
Bargonetti, J.7
Bartel, F.8
Taubert, H.9
Wuerl, P.10
Onel, K.11
Yip, L.12
Hwang, S.-J.13
Strong, L.C.14
Lozano, G.15
Levine, A.J.16
-
6
-
-
33746218700
-
No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer
-
DOI 10.1016/j.canlet.2005.09.003, PII S0304383505008335
-
IG Campbell DM Eccles DY Choong 2006 No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer Cancer Lett 240 195 197 10.1016/j.canlet.2005.09.003 1:CAS:528:DC%2BD28XntlGjtbo%3D 16239061 (Pubitemid 44093819)
-
(2006)
Cancer Letters
, vol.240
, Issue.2
, pp. 195-197
-
-
Campbell, I.G.1
Eccles, D.M.2
Choong, D.Y.H.3
-
7
-
-
33645459643
-
No association between the MDM2-309 T/G promoter polymorphism and breast cancer in African-Americans or Whites
-
10.1158/1055-9965.EPI-05-0692 1:CAS:528:DC%2BD28XmvVSnsQ%3D%3D 16434608
-
RC Millikan K Heard S Winkel EJ Hill B Massa L Mayes P Williams R Holston K Conway S Edmiston AR de Cotret 2006 No association between the MDM2-309 T/G promoter polymorphism and breast cancer in African-Americans or Whites Cancer Epidemiol Biomarkers Prev 15 175 177 10.1158/1055-9965.EPI-05-0692 1:CAS:528:DC%2BD28XmvVSnsQ%3D%3D 16434608
-
(2006)
Cancer Epidemiol Biomarkers Prev
, vol.15
, pp. 175-177
-
-
Millikan, R.C.1
Heard, K.2
Winkel, S.3
Hill, E.J.4
Massa, B.5
Mayes, L.6
Williams, P.7
Holston, R.8
Conway, K.9
Edmiston, S.10
De Cotret, A.R.11
-
8
-
-
33746239400
-
Polymorphisms in the MDM2 promoter and risk of breast cancer: A case-control analysis in a Chinese population
-
DOI 10.1016/j.canlet.2005.09.019, PII S0304383505008670
-
H Ma Z Hu X Zhai S Wang X Wang J Qin G Jin J Liu Q Wei H Shen 2006 Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population Cancer Lett 240 261 267 10.1016/j.canlet.2005. 09.019 1:CAS:528:DC%2BD28XntlGjurs%3D 16288830 (Pubitemid 44093826)
-
(2006)
Cancer Letters
, vol.240
, Issue.2
, pp. 261-267
-
-
Ma, H.1
Hu, Z.2
Zhai, X.3
Wang, S.4
Wang, X.5
Qin, J.6
Jin, G.7
Liu, J.8
Wang, X.9
Wei, Q.10
Shen, H.11
-
9
-
-
33745612767
-
Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
-
DOI 10.1186/1471-2407-6-80
-
ER Copson HE White JP Blaydes DO Robinson PW Johnson DM Eccles 2006 Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers BMC Cancer 6 80 10.1186/1471-2407-6-80 16563154 (Pubitemid 43983118)
-
(2006)
BMC Cancer
, vol.6
, pp. 80
-
-
Copson, E.R.1
White, H.E.2
Blaydes, J.P.3
Robinson, D.O.4
Johnson, P.W.5
Eccles, D.M.6
-
10
-
-
33845944092
-
Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk
-
1:CAS:528:DC%2BD2sXps1SqtA%3D%3D 17214373
-
A Petenkaya B Bozkurt O Akilli-Ozturk HS Kaya B Gur-Dedeoglu IG Yulug 2006 Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk Anticancer Res 26 4975 4977 1:CAS:528:DC%2BD2sXps1SqtA%3D%3D 17214373
-
(2006)
Anticancer Res
, vol.26
, pp. 4975-4977
-
-
Petenkaya, A.1
Bozkurt, B.2
Akilli-Ozturk, O.3
Kaya, H.S.4
Gur-Dedeoglu, B.5
Yulug, I.G.6
-
11
-
-
31544482118
-
The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer
-
DOI 10.1158/0008-5472.CAN-05-3168
-
S Wilkening JL Bermejo B Burwinkel R Klaes CR Bartram A Meindl P Bugert RK Schmutzler B Wappenschmidt M Untch K Hemminki A Forsti 2006 The single nucleotide polymorphism IVS1 + 309 in mouse double minute 2 does not affect risk of familial breast cancer Cancer Res 66 646 648 10.1158/0008-5472.CAN-05-3168 1:CAS:528:DC%2BD28XlsFOlsw%3D%3D 16423991 (Pubitemid 43165924)
-
(2006)
Cancer Research
, vol.66
, Issue.2
, pp. 646-648
-
-
Wilkening, S.1
Bermejo, J.L.2
Burwinkel, B.3
Klaes, R.4
Bartram, C.R.5
Meindl, A.6
Bugert, P.7
Schmutzler, R.K.8
Wappenschmidt, B.9
Untch, M.10
Hemminki, K.11
Forsti, A.12
-
12
-
-
34249982811
-
The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies
-
DOI 10.1007/s10552-007-9004-x
-
DG Cox D Deer Q Guo SS Tworoger SE Hankinson DJ Hunter I De Vivo 2007 The p53 Arg72Pro and MDM2-309 polymorphisms and risk of breast cancer in the nurses' health studies Cancer Causes Control 18 621 625 10.1007/s10552-007-9004- x 17387621 (Pubitemid 46883679)
-
(2007)
Cancer Causes and Control
, vol.18
, Issue.6
, pp. 621-625
-
-
Cox, D.G.1
Deer, D.2
Guo, Q.3
Tworoger, S.S.4
Hankinson, S.E.5
Hunter, D.J.6
De Vivo, I.7
-
13
-
-
34447540243
-
MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling
-
DOI 10.1007/s10549-006-9407-5
-
M Wasielewski JH Nagel C Brekelmans JG Klijn A van den Ouweland H Meijers-Heijboer M Schutte 2007 MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling Breast Cancer Res Treat 104 153 157 10.1007/s10549-006-9407-5 1:CAS:528:DC%2BD2sXnvFKnu7g%3D 17080308 (Pubitemid 47084228)
-
(2007)
Breast Cancer Research and Treatment
, vol.104
, Issue.2
, pp. 153-157
-
-
Wasielewski, M.1
Nagel, J.H.A.2
Brekelmans, C.3
Klijn, J.G.M.4
Van Den Ouweland, A.5
Meijers-Heijboer, H.6
Schutte, M.7
-
14
-
-
35148876519
-
Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium
-
DOI 10.1158/0008-5472.CAN-07-0738
-
MK Schmidt S Reincke A Broeks LM Braaf FB Hogervorst RA Tollenaar N Johnson O Fletcher J Peto J Tommiska C Blomqvist HA Nevanlinna CS Healey AM Dunning PD Pharoah DF Easton T Dork LJ Van't Veer 2007 Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium Cancer Res 67 9584 9590 10.1158/0008-5472.CAN-07-0738 1:CAS:528:DC%2BD2sXhtFSnurjL 17909070 (Pubitemid 47535950)
-
(2007)
Cancer Research
, vol.67
, Issue.19
, pp. 9584-9590
-
-
Schmidt, M.K.1
Reincke, S.2
Broeks, A.3
Braaf, L.M.4
Hogervorst, F.B.L.5
Tollenaar, R.A.E.M.6
Johnson, N.7
Fletcher, O.8
Peto, J.9
Tommiska, J.10
Blomqvist, C.11
Nevanlinna, H.A.12
Healey, C.S.13
Dunning, A.M.14
Pharoah, P.D.P.15
Easton, D.F.16
Dork, T.17
Van't Veer, L.J.18
-
15
-
-
51649118386
-
MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent
-
10.1007/s10549-007-9797-z 1:CAS:528:DC%2BD1cXhtV2js7bP 18026875
-
RI Yarden E Friedman S Metsuyanim T Olender E Ben-Asher MZ Papa 2008 MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent Breast Cancer Res Treat 111 497 504 10.1007/s10549-007-9797-z 1:CAS:528:DC%2BD1cXhtV2js7bP 18026875
-
(2008)
Breast Cancer Res Treat
, vol.111
, pp. 497-504
-
-
Yarden, R.I.1
Friedman, E.2
Metsuyanim, S.3
Olender, T.4
Ben-Asher, E.5
Papa, M.Z.6
-
16
-
-
41849110219
-
MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population
-
10.1093/carcin/bgn024 1:CAS:528:DC%2BD1cXktlOgsLw%3D 18281248
-
SS Lum HW Chua H Li WF Li N Rao J Wei Z Shao K Sabapathy 2008 MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population Carcinogenesis 29 754 761 10.1093/carcin/bgn024 1:CAS:528:DC%2BD1cXktlOgsLw%3D 18281248
-
(2008)
Carcinogenesis
, vol.29
, pp. 754-761
-
-
Lum, S.S.1
Chua, H.W.2
Li, H.3
Li, W.F.4
Rao, N.5
Wei, J.6
Shao, Z.7
Sabapathy, K.8
-
17
-
-
46249094186
-
MDM2 SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk
-
DOI 10.1159/000139135
-
D Krekac K Brozkova D Knoflickova R Hrstka P Muller R Nenutil B Vojtesek 2008 MDM2SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk Oncology 74 84 87 10.1159/000139135 1:CAS:528: DC%2BD1cXnvFSjsLg%3D 18547962 (Pubitemid 351915014)
-
(2008)
Oncology
, vol.74
, Issue.1-2
, pp. 84-87
-
-
Krekac, D.1
Brozkova, K.2
Knoflickova, D.3
Hrstka, R.4
Muller, P.5
Nenutil, R.6
Vojtesek, B.7
-
18
-
-
55349146001
-
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
-
10.1186/1471-2407-8-281 18828900
-
FE Paulin M O'Neill G McGregor A Cassidy A Ashfield CW Ali AJ Munro L Baker CA Purdie DP Lane AM Thompson 2008 MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism BMC Cancer 8 281 10.1186/1471-2407-8-281 18828900
-
(2008)
BMC Cancer
, vol.8
, pp. 281
-
-
Paulin, F.E.1
O'Neill, M.2
McGregor, G.3
Cassidy, A.4
Ashfield, A.5
Ali, C.W.6
Munro, A.J.7
Baker, L.8
Purdie, C.A.9
Lane, D.P.10
Thompson, A.M.11
-
19
-
-
61849084791
-
Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer
-
10.1186/1471-2407-9-13 19144119
-
YF Sun JD Leu SM Chen IF Lin YJ Lee 2009 Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer BMC Cancer 9 13 10.1186/1471-2407-9-13 19144119
-
(2009)
BMC Cancer
, vol.9
, pp. 13
-
-
Sun, Y.F.1
Leu, J.D.2
Chen, S.M.3
Lin, I.F.4
Lee, Y.J.5
-
20
-
-
36549070713
-
Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women
-
DOI 10.1016/j.annepidem.2007.06.006, PII S1047279707002517
-
V Singh N Rastogi N Mathur K Singh MP Singh 2008 Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women Ann Epidemiol 18 48 57 10.1016/j.annepidem.2007.06.006 17719241 (Pubitemid 350184342)
-
(2008)
Annals of Epidemiology
, vol.18
, Issue.1
, pp. 48-57
-
-
Singh, V.1
Rastogi, N.2
Mathur, N.3
Singh, K.4
Singh, M.P.5
-
21
-
-
38849111754
-
MDM2 promoter polymorphism SNP309 contributes to tumor susceptibility: Evidence from 21 case-control studies
-
DOI 10.1158/1055-9965.EPI-07-0634
-
Z Hu G Jin L Wang F Chen X Wang H Shen 2007 MDM2 promoter polymorphism SNP309 contributes to tumor susceptibility: evidence from 21 case-control studies Cancer Epidemiol Biomarkers Prev 16 2717 2723 10.1158/1055-9965.EPI-07- 0634 1:CAS:528:DC%2BD2sXhsVenur3J 18086778 (Pubitemid 351196328)
-
(2007)
Cancer Epidemiology Biomarkers and Prevention
, vol.16
, Issue.12
, pp. 2717-2723
-
-
Hu, Z.1
Jin, G.2
Wang, L.3
Chen, F.4
Wang, X.5
Shen, H.6
-
22
-
-
36248995926
-
MDM2 SNP309 and cancer risk: A combined analysis
-
DOI 10.1093/carcin/bgm191
-
S Wilkening JL Bermejo K Hemminki 2007 MDM2 SNP309 and cancer risk: a combined analysis Carcinogenesis 28 2262 2267 10.1093/carcin/bgm191 1:CAS:528:DC%2BD2sXht1yktbbI 17827408 (Pubitemid 350119563)
-
(2007)
Carcinogenesis
, vol.28
, Issue.11
, pp. 2262-2267
-
-
Wilkening, S.1
Bermejo, J.L.2
Hemminki, K.3
-
23
-
-
0041876133
-
Measuring inconsistency in meta-analyses
-
10.1136/bmj.327.7414.557 12958120
-
JP Higgins SG Thompson JJ Deeks DG Altman 2003 Measuring inconsistency in meta-analyses BMJ 327 557 560 10.1136/bmj.327.7414.557 12958120
-
(2003)
BMJ
, vol.327
, pp. 557-560
-
-
Higgins, J.P.1
Thompson, S.G.2
Deeks, J.J.3
Altman, D.G.4
-
24
-
-
0028659004
-
Operating characteristics of a rank correlation test for publication bias
-
10.2307/2533446 1:STN:280:DyaK2Mzgs1GrtQ%3D%3D 7786990
-
CB Begg M Mazumdar 1994 Operating characteristics of a rank correlation test for publication bias Biometrics 50 1088 1101 10.2307/2533446 1:STN:280:DyaK2Mzgs1GrtQ%3D%3D 7786990
-
(1994)
Biometrics
, vol.50
, pp. 1088-1101
-
-
Begg, C.B.1
Mazumdar, M.2
-
25
-
-
65349179110
-
Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations
-
10.1186/1471-2407-9-60 19226467
-
H Nechushtan T Hamburger S Mendelson L Kadouri N Sharon E Pikarsky T Peretz 2009 Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations BMC Cancer 9 60 10.1186/1471-2407-9-60 19226467
-
(2009)
BMC Cancer
, vol.9
, pp. 60
-
-
Nechushtan, H.1
Hamburger, T.2
Mendelson, S.3
Kadouri, L.4
Sharon, N.5
Pikarsky, E.6
Peretz, T.7
-
26
-
-
33744899069
-
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
-
DOI 10.1158/0008-5472.CAN-06-0180
-
GL Bond KM Hirshfield T Kirchhoff G Alexe EE Bond H Robins F Bartel H Taubert P Wuerl W Hait D Toppmeyer K Offit AJ Levine 2006 MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner Cancer Res 66 5104 5110 10.1158/0008-5472.CAN-06-0180 1:CAS:528: DC%2BD28XksF2isr0%3D 16707433 (Pubitemid 43844932)
-
(2006)
Cancer Research
, vol.66
, Issue.10
, pp. 5104-5110
-
-
Bond, G.L.1
Hirshfield, K.M.2
Kirchhoff, T.3
Alexe, G.4
Bond, E.E.5
Robins, H.6
Bartel, F.7
Taubert, H.8
Wuerl, P.9
Hait, W.10
Toppmeyer, D.11
Offit, K.12
Levine, A.J.13
-
27
-
-
67649550721
-
MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians
-
Gui XH, Qiu LX, Zhang HF, Zhang DP, Zhong WZ, Li J, Xiao YL (2009) MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians. Eur J Cancer 45(11):2023-2026
-
(2009)
Eur J Cancer
, vol.45
, Issue.11
, pp. 2023-2026
-
-
Gui, X.H.1
Qiu, L.X.2
Zhang, H.F.3
Zhang, D.P.4
Zhong, W.Z.5
Li, J.6
Xiao, Y.L.7
-
28
-
-
0030053794
-
Abnormal expression of MDM-2 in breast carcinomas
-
DOI 10.1007/BF01806499
-
CE Bueso-Ramos T Manshouri MA Haidar Y Yang P McCown N Ordonez A Glassman N Sneige M Albitar 1996 Abnormal expression of MDM-2 in breast carcinomas Breast Cancer Res Treat 37 179 188 10.1007/BF01806499 1:STN:280: DyaK28zmt1WrsA%3D%3D 8750585 (Pubitemid 26030095)
-
(1996)
Breast Cancer Research and Treatment
, vol.37
, Issue.2
, pp. 179-188
-
-
Bueso-Ramos, C.E.1
Manshouri, T.2
Haidar, M.A.3
Yang, Y.4
McCown, P.5
Ordonez, N.6
Glassman, A.7
Sneige, N.8
Albitar, M.9
-
29
-
-
67449103007
-
Cigarette smoking, MDM2 SNP309, gene-environment interactions, and lung cancer risk: A meta-analysis
-
10.1080/15287390902840930 1:CAS:528:DC%2BD1MXmslCjsr0%3D 19492228
-
J Bai J Dai H Yu H Shen F Chen 2009 Cigarette smoking, MDM2 SNP309, gene-environment interactions, and lung cancer risk: a meta-analysis J Toxicol Environ Health A 72 677 682 10.1080/15287390902840930 1:CAS:528: DC%2BD1MXmslCjsr0%3D 19492228
-
(2009)
J Toxicol Environ Health A
, vol.72
, pp. 677-682
-
-
Bai, J.1
Dai, J.2
Yu, H.3
Shen, H.4
Chen, F.5
-
30
-
-
37549017282
-
Oral contraceptive use and risk of breast cancer
-
quiz 90-81
-
Casey PM, P.M. Cerhan PM, Pruthi S (2008) Oral contraceptive use and risk of breast cancer. Mayo Clin Proc 83:86-90; quiz 90-81
-
(2008)
Mayo Clin Proc
, vol.83
, pp. 86-90
-
-
Casey, P.M.1
Pm Cerhan, P.M.2
Pruthi, S.3
-
31
-
-
66649098171
-
Minireview: Obesity and breast cancer: The estrogen connection
-
10.1210/en.2009-0070 1:CAS:528:DC%2BD1MXmvVCqt7Y%3D 19372199
-
MP Cleary ME Grossmann 2009 Minireview: obesity and breast cancer: the estrogen connection Endocrinology 150 2537 2542 10.1210/en.2009-0070 1:CAS:528:DC%2BD1MXmvVCqt7Y%3D 19372199
-
(2009)
Endocrinology
, vol.150
, pp. 2537-2542
-
-
Cleary, M.P.1
Grossmann, M.E.2
|